AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06719388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: combination of exercise therapy and a jaw-mobilizing device
Description: Participants in the experimental group will receive a combination of exercise therapy and a jaw-mobilizing device. The intervention includes structured exercise therapy sessions and the use of the jaw-mobilizing device for 12 weeks, beginning one week prior to radiotherapy. Follow-ups will occur at weeks 16, 24, and 36 to assess outcomes.
Study NCT06719388 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: exercise therapy only
Description: Participants in the control group will receive exercise therapy only. This intervention involves the same structured exercise therapy sessions as the experimental group for 12 weeks, beginning one week prior to radiotherapy. Follow-ups will occur at weeks 16, 24, and 36 to assess outcomes.
Study NCT06719245 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Targeted Muscle Reinnervation (TMR)
Description: In short: each transected nerve is identified after amputation and is dissected proximally for length. A nerve stimulator is used to identify functional motor nerve branches. Near the point where the motor branch enters the muscle, the motor nerve branch is transected and an end-to-end coaptation is performed with a nearby amputated nerve.
Study NCT06719245 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard neurectomy
Description: During the amputation a standard neurectomy will be performed based on the surgeons preference. Standard neurectomy will include cutting of the nerve, with or without traction, with or without coagulation, and with or without infiltration with a local anesthetic (i.e., ropivacaine) or phenol. Ligation of the nerve will not be allowed.
Study NCT06715202 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patient Education Booklet
Description: Before the surgery, a personal information form and the SF-36 Quality of Life Scale will be filled out. The educational content regarding the problems that these patients may encounter with the DJ stent after the surgery until they are discharged will be explained in sections and the patients' questions will be answered. When the patient comes to the hospital for DJ stent removal 4 weeks after discharge, the Ureteral Stent Symptom 1st Questionnaire and the SF-36 Quality of Life Scale will be filled out while the DJ stent is in place. The Ureteral Stent Symptom 2nd Questionnaire and the SF-36 Quality of Life Scale will be applied 4 weeks after the stent is removed. The education booklet will be prepared by the researchers in accordance with the recommendations of the European Association of Urology and the relevant literature.
Study NCT06716554 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Shatavari extract
Description: Shatavari is scientifically known as Asparagus racemosus. One capsule containing Shatavari 300mg should be taken once daily.
Study NCT06716554 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Shatavari + Ashwagandha extract
Description: Shatavari is scientifically known as Asparagus racemosus along with Ashwagandha root extract scientifically known as Withania somnifera. One capsule containing Shatavari 300mg + Ashwagandha root extract 250mg should be taken once daily.
Study NCT06716554 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (starch)
Study NCT06715215 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Acute phase proteins
Description: Assessment of acute phase proteins levels in patients diagnosed with immune thrombocytopenia
Study NCT06718400 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel Skin Flap
Description: Willing participants who will be receiving an intestinal transplantation will receive a sentinel skin flap on their forearm from the same donor
Study NCT06716840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: participants in the remimazolam group received remimazolam besylate intravenously at an initial infusion rate of 0.2mg/kg/h and adjusted (maximum of 2 mg/kg/h) to maintain a Richmond Agitation-Sedation Scale(RASS) score between - 2 and 0.If the maximum dose of remimazolam was insufficient to sedate, add rescue dexmedetomidine.
Study NCT06716840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: participants in the propofol group received propofol intravenously at an initial infusion rate of 1 mg/kg/h and adjusted (maximum of 4 mg/kg/h) to maintain a Richmond Agitation-Sedation Scale (RASS) score between - 2 and 0.If the maximum dose of propofol was insufficient to sedate, add rescue dexmedetomidine.
Study NCT06715956 — intervention group
Intervention type: OTHER
Intervention: Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis
Description: This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.
Study NCT06714838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab (Mabthera)
Description: Rituximab will be administered in a hospital setting in the course of one day. It will be given intravenously, at time points baseline, week 2 and week 26.
Study NCT05743374 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Normal diet
Description: These patients will be given advice about a normal healthy diet.
Study NCT05743374 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: E400 elimination
Description: Patients in the intervention group will be given advice how to eliminate E440 additives with regard to carragenan, CMC and polysorbates.
Study NCT05849597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h.
Study NCT05849597 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h.
Study NCT04948112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: real time continuous glucose monitor
Description: CGM sensor will read blood glucose every 10 minutes
Study NCT04948112 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: blinded continuous glucose monitor
Description: CGM that records blood glucose but not visible to patient
Study NCT04622397 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision
Study NCT04622397 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision
Study NCT06221553 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: B7H3 specific CAR T cell with IL-7Ra signaling domain
Description: Autologous T cells lentivirally transduced to express a B7H3 specific chimeric antigen receptor (CAR) with additional of IL-7 receptor alpha signalingdomain given via indwelling central nervous system (CNS) catheter
Study NCT05757323 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: infant formula based on hydrolyzed protein
Description: infant formula based on hydrolysed protein
Study NCT05757323 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: infant formula based on intact protein
Description: infant formula based on intact protein
Study NCT05314894 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: Giving training to the students in the initiative group to quit smoking in three sessions, sending messages via whatsapp program and telephone counseling
Study NCT05307887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sync VR Medical PICO G2 4K Virtual Reality Technology
Description: Virtual reality headset and software
Study NCT04665375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DOR/3TC/TDF
Description: switch antiretroviral regimen to doravirine/lamivudine/tenofovir disoproxil fumarate once daily for 1 year
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ergocalciferol supplementation
Description: Participants in both groups will recieve ergocalciferol with different supplementation regimens for 6 months.
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ergocalciferol supplementation
Description: Participants in both groups will recieve ergocalciferol with different supplementation regimens for 6 months.
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dialysis techniques
Description: Both groups will have participants treated with maintenance hemodialysis and peritoneal dialysis.
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dialysis techniques
Description: Both groups will have participants treated with maintenance hemodialysis and peritoneal dialysis.
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sunlight exposure time
Description: Both groups will be advised to receive similar hours of daily sunlight exposure time.
Study NCT05434377 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sunlight exposure time
Description: Both groups will be advised to receive similar hours of daily sunlight exposure time.
Study NCT04777578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling based on fast-in fast-out technique in the teresa major muscle
Study NCT06512025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WWWT psychoeducative intervention
Description: What Were We Thinking (WWWT) is a highly structured, interactive, gender-informed, couples-based, psycho-educational program for parents and a first newborn to promote confident parental caretaking, optimize functioning in the intimate partner relationship and improve infant care manageability.~The adaptation of the WWWT programme (Catalan and Spanish version) comprises 2 sessions, each lasting 2 hours, that will be designed for groups of 5-7 families - within the first 6 weeks postpartum -, each consisting of mother, partner (or other caregiver) and their infant(s).
Study NCT04963595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: 400 mg once daily
Study NCT04963595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Initial dose 70 mg/m2 on days 1 and 8 (capsules) If well tolerated, subsequently 90 mg/m2 on days 1 and 8. Capsules on day 1 to be taken at the hospital, and on day 8 at home.
Study NCT04963595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inetetamab
Description: 8mg/kg iv day 1 followed by 6mg/kg iv day 1, cycled every 21 days
Study NCT05365009 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multidisciplinary aproach
Description: regular tests
Study NCT05028673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Capsule
Description: Hard capsule
Study NCT06131658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional motor control excercise
Description: This include functional motor control thrice a week for six weeks
Study NCT06131658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: convectional excercise
Description: This include convectional exercise thrice a week for six weeks
Study NCT06141824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lucira COVID-19 & Flu Test
Description: The Lucira COVID-19 \& Flu Test is a rapid, single-use, molecular test for the qualitative detection and discrimination of SARS-CoV-2, Influenza A, and Influenza B viral RNA in nasal swab samples.
Study NCT06406660 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test
Description: This study conducts drug sensitivity tests on various clinically approved drugs. The most sensitive drug for the patient is selected for treatment. This study aims to evaluate the clinical effectiveness of treatment plans guided by organoid drug sensitivity tests.
Study NCT05495438 — intervention group
Intervention type: OTHER
Intervention: Hypothetical AI
Description: n/a - There is no intervention. Clinicians will review the suggestions of a hypothetical AI
Study NCT05028673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Tablet
Description: Film-coated tablet
Study NCT05028673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antacid
Description: Oral suspension
Study NCT04672018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Houtou Jianweiling tablet
Description: Houtou Jianweiling tablet (0.38 g), 4 tablets taken orally at a time, 3 times a day and Omeprazole Enteric-coated placebo tablet, taken 1 tablet orally once a day before breakfast.
Study NCT04672018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omeprazole Tablet
Description: Omeprazole Enteric-coated tablet (20 mg), 1 tablet taken orally once a day before breakfast and Houtou Jianweiling placebo tablets, taken orally, 4 tablets at a time, 3 times a day.
Study NCT05953870 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: slower tempo music that can quiet mind and make patients feel soothed
Study NCT05830942 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking Exercise
Description: aerobic walking exercise using complex (cognitively engaging) walking tasks
Study NCT05830942 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Walking Exercise
Description: aerobic walking exercise using complex (cognitively engaging) walking tasks
Study NCT05830942 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prefrontal Active tDCS
Description: 20 minutes of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session
Study NCT05830942 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Prefrontal Sham tDCS
Description: 30 seconds of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session
Study NCT05815030 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.
Study NCT05815030 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.
Study NCT04708886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romosozumab
Description: Year 1 study drug
Study NCT04708886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alendronate
Description: Year 2 study drug
Study NCT05655247 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Split-thickness non-advanced tunnel (Zabalegui et al. 1999)
Description: A split-thickness non-advanced tunnel will be performed according to Zabalegui et al. (1999).
Study NCT05655247 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Full-thickness coronally-advanced tunnel (Aroca et al. 2010)
Description: A full-thickness coronally-advanced tunnel (Modified Coronally Advanced Tunnel - MCAT) will be performed according to Aroca et al. (2010).
Study NCT05209581 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Distance Visual Acuity Examination
Description: Best spectacle-corrected distance visual acuity of refugees/immigrants will be examined via a web-based digital visual acuity chart
Study NCT06521944 — intervention group
Intervention type: BIOLOGICAL
Intervention: RSV Vaccine
Description: RSV Vaccine approved for administration to pregnant individuals between 32 weeks, 0 days and 36 weeks, 6 days of gestation
Study NCT06521944 — intervention group
Intervention type: OTHER
Intervention: Non-exposure to RSV Vaccine
Description: Pregnant individuals who are not exposed to the RSV vaccine
Study NCT06322394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: high-dose BXOS110
Description: 3.0 mg/kg, maximum dose not exceeding 300 mg，Participants received one administration by intravenous infusion.
Study NCT06322394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: low-dose BXOS110
Description: 2.0 mg/kg, maximum dose not exceeding 200 mg，Participants received one administration by intravenous infusion.
Study NCT06322394 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Does not contain any test drug active ingredients，Participants received one administration by intravenous infusion.
Study NCT04696107 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducative intervention
Description: This workshop is centred in psychoeducational and training action in emotional self-regulation in a group modality and participatory character, aimed at patients with mCNCP to acquire basic knowledge in:~* Neurology and psychoneuroimmunology.~* The role of beliefs in our manifestation of the disease.~* Body language and modulation of pain perception.~* Relaxation body-mind techniques.~* Creative visualization for pain management.~* Mirror feed-back.~The workshop will take place at the Hospital San Juan de Dios del Aljarafe, in four weeks, once a week, three hours each. Until now, the attendance was 24 patients per workshop. After the pandemic, we will reduce to 15 to increase safety distance. We will also conduct a telephone survey of each patient on symptoms of Covid infection in the 24 hours prior to the workshop.
Study NCT06045819 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling for venetoclax drug dosage (venous puncture)
Description: 8 blood samples for venetoclax and azole antifungal drugs identification and dosage will be taken by venous and capillary punctures throughout management of patients
Study NCT06456437 — intervention group
Intervention type: DEVICE
Intervention: Post-conditioning Balloon dilation and contraction
Description: The balloon was filled at a pressure of no more than 4 atm at the original occlusion of the vessel to block blood flow for 2 minutes (confirmed by angiography), and then contracted to reperfuse the blood flow for 2 minutes, and the above steps were repeated 4 times to complete the in situ ischaemic post-acclimatisation intervention.
Study NCT05320848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cardiac rehabilitation
Description: Cardiac rehabilitation is a valuable treatment for patients with a broad spectrum of cardiac disease.
Study NCT04866849 — intervention group
Intervention type: OTHER
Intervention: examination
Description: The presence of bruxism was based on self-reported bruxism and examination. Self reported bruxism was recorded as yes or no . Participants were examined for the existence of four clinical signs of bruxism: (I) abnormal tooth wear, (II) impressions of teeth in the buccal area, (III) impressions of teeth on the tongue, and (IV) hypertrophy of the masseter muscle. In this study, clinical signs of bruxism were considered present if one of the four items was answered yes.
Study NCT05460559 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Group A (p-PCNL) procedure
Description: In lithotomy position, ureteric catheter will be inserted allowing injection of contrast to obtain a pyelogram. Shifting the patients in prone position will be done. Under fluoroscopic guidance, the desired calyces will be punctured using an 18 G coaxial needle. Then 0.038 mm hydrophilic guidewires will be passed percutaneously through the needle into the pelvis. Using metal dilators dilatation will be carried out. Amplatz sheath will be inserted to allow nephroscope to enter the collecting system. Stone disintegration will be performed using pneumatic, ultrasonic or laser lithotripsy. Eventually after removal of all stone fragments, a nephrostomy tube will be placed.